BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7236157)

  • 41. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis.
    Morison WL; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1978 Feb; 98(2):125-32. PubMed ID: 629867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A; Seeber A
    Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients' attitudes to treatment of psoriasis with oral psoralen photochemotherapy.
    Dick DC; Roberts DT
    Health Bull (Edinb); 1982 Nov; 40(6):290-5. PubMed ID: 7161098
    [No Abstract]   [Full Text] [Related]  

  • 45. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Oral photochemotherapy of psoriasis (author's transl)].
    Frenk E
    Ther Umsch; 1982 Mar; 39(3):208-11. PubMed ID: 7089909
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis.
    Almutawa F; Thalib L; Hekman D; Sun Q; Hamzavi I; Lim HW
    Photodermatol Photoimmunol Photomed; 2015 Jan; 31(1):5-14. PubMed ID: 24283358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
    Turjanmaa K; Salo H; Reunala T
    Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phototherapy and photochemotherapy of inflammatory dermatoses].
    Schiener R; Pillekamp H; Kerscher M; Peter RU
    MMW Fortschr Med; 2003 Feb; 145(8):45-7. PubMed ID: 12661442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.
    Chen X; Yang M; Cheng Y; Liu GJ; Zhang M
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009481. PubMed ID: 24151011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis.
    Brücke J; Tanew A; Ortel B; Hönigsmann H
    Br J Dermatol; 1991 Apr; 124(4):372-4. PubMed ID: 2025558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personal solar UV-A doses received by patients undergoing oral psoralen photochemotherapy for psoriasis.
    Moseley H; Diffey BL; Marks JM; Mackie RM
    Br J Dermatol; 1981 Nov; 105(5):573-7. PubMed ID: 7295572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis.
    Ortel B; Perl S; Kinaciyan T; Calzavara-Pinton PG; Hönigsmann H
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):736-40. PubMed ID: 8227546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
    Meffert H; Metz D
    Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
    [No Abstract]   [Full Text] [Related]  

  • 55. Current status of oral PUVA therapy for psoriasis. Eye protection revisions.
    J Am Acad Dermatol; 1982 May; 6(5):851-5. PubMed ID: 7096648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cream PUVA photochemotherapy].
    Stege H; Berneburg M; Ruzicka T; Krutmann J
    Hautarzt; 1997 Feb; 48(2):89-93. PubMed ID: 9173066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Audit of the use of psoralen photochemotherapy (PUVA) and narrowband UVB phototherapy in the treatment of psoriasis.
    Yones SS; Palmer RA; Kuno Y; Hawk JL
    J Dermatolog Treat; 2005 Apr; 16(2):108-12. PubMed ID: 16019625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides.
    Parrish JA; LeVine MJ; Fitzpatrick TB
    Int J Dermatol; 1980 Sep; 19(7):379-86. PubMed ID: 6998879
    [No Abstract]   [Full Text] [Related]  

  • 59. Photochemotherapy beyond psoriasis.
    Honig B; Morison WL; Karp D
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):775-90. PubMed ID: 7929924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.